4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Improving Prostate Cancer Outcome with Vectored Vaccines (IMPROVE)
Date du début: 1 avr. 2014, Date de fin: 31 mars 2018,
A successful vaccine against cancer is most likely to work through the induction of potent CD8+ T cells that can successfully kill tumour cells. But achieving this has proved difficult and only low level responses are induced by current vaccine approaches. Nonetheless, two therapeutic immunisation strategies have shown partial success in targeting prostate cancer, and one recently reached licensur ...
Voir le projet
5
Participants partenaires
TERMINÉ
Graphene-based disruptive technologies (GrapheneCore1)
Date du début: 1 avr. 2016, Date de fin: 31 mars 2018,
This project is the second in the series of EC-financed parts of the Graphene Flagship. The Graphene Flagship is a 10 year research and innovation endeavour with a total project cost of 1,000,000,000 euros, funded jointly by the European Commission and member states and associated countries. The first part of the Flagship was a 30-month Collaborative Project, Coordination and Support Action (CP-CS ...
Voir le projet
158
Participants partenaires
TERMINÉ
Graphene-Based Revolutions in ICT And Beyond (GRAPHENE)
Date du début: 1 oct. 2013, Date de fin: 31 mars 2016,
This Flagship aims to take graphene and related layered materials from a state of raw potential to a point where they can revolutionize multiple industries – from flexible, wearable and transparent electronics, to new energy applications and novel functional composites.Our main scientific and technological objectives in the different tiers of the value chain are to develop material technologies fo ...
Voir le projet
154
Participants partenaires
TERMINÉ
Advanced gene therapy tools for treatment of CNS-specific disorders (NEUGENE)
Date du début: 1 oct. 2008, Date de fin: 31 mars 2012,
"Curative therapies still do not exist for most CNS diseases but gene therapy is a promising new approach. We propose that it will be possible to modify brain function and pathophysiology by targeted delivery of specific curative factors to selected populations of brain cells that are affected by disease. This opens the door for effective treatment regimes, which can be tailored to individual pati ...
Voir le projet